Literature DB >> 30147139

Nonpharmacist Health Care Providers' Knowledge of and Opinions Regarding Medication Costs in Critically Ill Patients.

Drayton A Hammond1, Tiffany Chiu2, Jacob T Painter3, Nikhil Meena3.   

Abstract

Purpose: Medication cost is frequently overlooked when treating critically ill patients. Stewardship of health care resources in high-utilization settings is imperative. This study was conducted to determine nonpharmacist health care providers' knowledge and perceptions of medication costs in a medical intensive care unit (MICU).
Methods: Nonpharmacist health care providers in a MICU completed a 27-item survey. The survey queried perceptions regarding medication cost, cost-limiting strategies, and most/least expensive medications in 8 classes, medication price ranges, and intravenous-to-oral comparisons for commonly prescribed medications. Responses were analyzed using descriptive statistics and compared between providers using Fisher exact tests.
Results: Among 98 health care providers (76 medical trainees, 5 attending physicians, 17 nurses), when ordering a medication, 49% consider its cost. Few (15%) providers considered themselves knowledgeable regarding medication costs with no difference between providers (P = .174). Attending physicians were more aware of the most/least expensive medications than residents (correct out of 16: 9.6 vs 8.5, P = .044). The correct price ranges for select medications (11%-36%, P = .373) and intravenous-to-oral relative costs (3%-49%, P = .596) were similarly low. Most (59%) believed pharmacists limit expensive medication use, particularly senior physicians (58% resident vs 100% attending, P = .007).
Conclusion: In spite of a goal of cost consideration, most nonpharmacist health care providers are unaware of medication costs and fail to include them in decision making. These knowledge gaps and perceptions should inform future efforts to improve knowledge and attitudes regarding medication costs.

Entities:  

Keywords:  cost; critical care; pharmacist/physician issues

Year:  2017        PMID: 30147139      PMCID: PMC6102787          DOI: 10.1177/0018578717739005

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  19 in total

1.  Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs.

Authors:  Neil A Halpern; Stephen M Pastores; Robert J Greenstein
Journal:  Crit Care Med       Date:  2004-06       Impact factor: 7.598

2.  Physician-attributable differences in intensive care unit costs: a single-center study.

Authors:  Allan Garland; Ziad Shaman; John Baron; Alfred F Connors
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

3.  Assessment of prescribers' knowledge of the cost of medications.

Authors:  Brittany Cogdill; Jean M Nappi
Journal:  Ann Pharmacother       Date:  2012-02-07       Impact factor: 3.154

4.  Cost accounting of adult intensive care: methods and human and capital inputs.

Authors:  T W Noseworthy; E Konopad; A Shustack; R Johnston; M Grace
Journal:  Crit Care Med       Date:  1996-07       Impact factor: 7.598

5.  Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients.

Authors:  Drayton A Hammond; Niranjan Kathe; Anuj Shah; Bradley C Martin
Journal:  Pharmacotherapy       Date:  2016-12-20       Impact factor: 4.705

Review 6.  Training Physicians to Provide High-Value, Cost-Conscious Care: A Systematic Review.

Authors:  Lorette A Stammen; Renée E Stalmeijer; Emma Paternotte; Andrea Oudkerk Pool; Erik W Driessen; Fedde Scheele; Laurents P S Stassen
Journal:  JAMA       Date:  2015-12-08       Impact factor: 56.272

7.  Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.

Authors:  Jennifer M Polinski; Malcolm Maclure; Blair Marshall; Alan Cassels; Jessica Agnew-Blais; Amanda R Patrick; Sebastian Schneeweiss
Journal:  Can J Clin Pharmacol       Date:  2008-07-19

8.  Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States.

Authors:  Ahmed Aljabri; Yvonne Huckleberry; Jason H Karnes; Mahdi Gharaibeh; Hussam I Kutbi; Yuval Raz; Seongseok Yun; Ivo Abraham; Brian Erstad
Journal:  Blood       Date:  2016-10-28       Impact factor: 22.113

9.  The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada.

Authors:  Peter Tanuseputro; Walter P Wodchis; Rob Fowler; Peter Walker; Yu Qing Bai; Sue E Bronskill; Douglas Manuel
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 10.  Physician awareness of drug cost: a systematic review.

Authors:  G Michael Allan; Joel Lexchin; Natasha Wiebe
Journal:  PLoS Med       Date:  2007-09       Impact factor: 11.069

View more
  1 in total

1.  PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study.

Authors:  Megan A Rech; Payal K Gurnani; William J Peppard; Keaton S Smetana; Megan A Van Berkel; Drayton A Hammond; Alexander H Flannery
Journal:  Crit Care Explor       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.